Biomarkers like DPP-4 have emerged as endotype-specific markers, with data from the ProRaD cohort linking them to clinical features such as keratosis pilaris, perleche, and eosinophilia, highlighting the systemic impact of inflammation even in milder disease (EASI < 16) [10]. This evidence concerns the gene DPP4 and keratosis pilaris.